Orthopedic Biomaterials Market Size

Orthopedic Biomaterials Market size was over USD 17.92 billion in 2024 and is set to reach USD 56.11 billion by the end of 2037, growing at around 9.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of orthopedic biomaterials is assessed at USD 19.24 billion.

The major factor attributed to the growth of the market is the rising prevalence of musculoskeletal diseases all over the world. Musculoskeletal diseases in a human usually affect the joints, bones, and muscles, and aid the development of other pain conditions and inflammatory diseases. Treatment of such musculoskeletal conditions requires orthopedic biomaterials for an effective healing process which in turn is expected to propel market expansion. As per the statistics shared by the World Health Organization (WHO) in 2022, approximately 1.71 billion people were affected by musculoskeletal conditions all over the world.

In addition to the aforementioned factors, other factors that are attributed to market growth is the rising chronic skeletal conditions among the global population which requires orthopedic biomaterials in the treatment process. Furthermore, the world has seen a surge in various kinds of orthopedic illnesses owing to the high engagement in a sedentary lifestyle and consumption of fatty and processed food items. Also, the burgeoning geriatric population which is more prone to various musculoskeletal ailments is considered to positively contribute to market expansion. In addition, the escalation in the number of trauma cases owing to injuries from accidents coupled with the increased number of sports injuries is also anticipated to bring lucrative growth opportunities for market expansion during the forecast period. Moreover, the growing demand for technologically advanced orthopedic biomaterials for treating various kinds of diseases is propelling the key player in the market to invest more in research and development activities. This factor is anticipated to impetus robust revenue generation in the upcoming years. Another factor that is anticipated to aid market growth is the rising number of orthopedic surgeries such as joint arthroplasty, joint reconstruction, and viscosupplementation which is expected to generate a demand for orthopedic biomaterials.